News
A non-binary media professional was shocked to receive a hostile rejection email because of the ‘they/them’ email signature ...
SAN FRANCISCO, June 30, 2025 /PRNewswire/ -- To celebrate 25 years since the ESIGN Act made digital signatures legal, Docusign (NASDAQ: DOCU) will drop six new signature styles that let you sign ...
Ramp reports that a clear corporate credit card policy is essential for managing employee spending, reducing fraud, and ...
Gateway Commercial Finance reports on the importance of financial stress testing for small businesses to prepare for economic ...
Durham-based GeneCentric Therapeutics, a cancer diagnostics company, has closed on an $8 million round of venture capital to launch and commercialize a novel liquid biopsy platform for guiding ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
An interview with Allan Thygesen, CEO of Docusign, about the e-signature vendor's repositioning to use AI to digitize ...
14d
Medical Device Network on MSNGeneCentric secures $8m to launch liquid biopsy platformGeneCentric Therapeutics has earned an initial $8m in a Series C funding round, marking a step towards the launch and ...
If the percentage of valid signatures in the sample is low enough that, when applied to the submitted total of some 11,000, the estimate of valid signatures is less than 90 percent of the required ...
New contract prep tools will also make it easier to populate templates with data from across a company’s systems. Later this year, Docusign expects to roll out more advanced AI agents that can ...
PaayaTech Releases Company-Wide Outlook Email Signatures & Disclaimers to CorpSync. - RochesterFirst
Easily align signatures with your brand guidelines by adding logos, marketing banners, contact details, social media links, and legal disclaimers. CorpSync’s dynamic templates automatically pull ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results